Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

MDS Diagnosis: Many Patients May Not Require Bone Marrow Examination

Blood (2018) 132 (Supplement 1): 4357.

https://doi.org/10.1182/blood-2018-99-111838

Published: 2018

Journal Articles

Deriving Core Patient-Reported Outcomes in Patients with Myelodysplastic Syndromes — a Delphi Survey from the European-MDS Registry

Igor Stojkov, MSc, Annette Conrads-Frank, PhD, Ursula Rochau, MD PhD, Karin A Koinig, PhD, Helena Borba, PhD, Marjan Arvandi, PhD, Pierre Fenaux, MD PhD, Argiris Symeonidis, MD PhD, David Bowen, MD PhD, Moshe Mittelman, MD, Corine van Marrewijk, PhD, Theo de Witte, MD PhD, Fabio Efficace, PhD, Uwe Siebert, MD PhD, Reinhard Stauder, MD MSc

Blood (2018) 132 (Supplement 1): 2295.

https://doi.org/10.1182/blood-2018-99-112063

Published: 2018

Journal Articles

Impact of Treatment with Iron Chelators in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry

Blood (2016) 128 (22): 3186.

https://doi.org/10.1182/blood.V128.22.3186.3186

Published: 2016

Journal Articles

An EBMT Prospective Non-Interventional Study of Outcomes and Toxicity of Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Patients Previously Treated with Second Generation Tyrosine Kinase Inhibitors

Blood (2016) 128 (22): 628.

https://doi.org/10.1182/blood.V128.22.628.628

Published: 2016

Journal Articles

Elevated Labile Plasma Iron Levels (LPI) and Increased Oxidative Stress Are Associated with Red Blood Cell Transfusions in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Subtitle: from the European Leukemianet MDS Registry

Marlijn Hoeks, MD, Saskia Langemeijer, MD PhD, Louise De Swart, MD, Tim Bagguley, Corine van Marrewijk, PhD, David Bowen, MD PhD, Jaroslav Cermak, Eva Hellstrom-Lindberg, MD PhD, Aurelia Tatic, MD, Argiris Symeonidis, Marian G.J. Van Kraaij, MD PhD, Panagiotis Panagiotidis, Hege Garelius, MD, Dominic J Culligan, Marta Krejci, MD PhD, Jackie Droste, PhD, Alexandra Smith, PhD, Dorine W. Swinkels, MD PhD, Theo de Witte, MD PhD

Blood (2016) 128 (22): 4327.

https://doi.org/10.1182/blood.V128.22.4327.4327

Published: 2016

Journal Articles

Labile Plasma Iron (LPI) Is a Clinical Indicator of Overt Iron Overload in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS Registry

Louise De Swart, MD, Chloé Reiniers, Tim Bagguley, David Bowen, MD PhD, Jaroslav Cermak, MD PhD, Eva Hellström-Lindberg, MD PhD, Aurelia Tatic, MD, Argiris Symeonidis, MD PhD, Gerwin Huls, MD PhD, Panagiotis Panagiotidis, Hege Garelius, MD, Dominic Culligan, Marta Krejci, Corine van Marrewijk, Jackie Droste, PhD, Alexandra Smith, Dorine W. Swinkels, MD PhD, Theo de Witte, MD PhD

Blood (2015) 126 (23): 2865.

https://doi.org/10.1182/blood.V126.23.2865.2865

Published: 2015

Journal Articles

Allogeneic Stem Cell Transplantation for MDS Patients More Than 70 Years of Age: a Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT

Blood (2015) 126 (23): 4390.

https://doi.org/10.1182/blood.V126.23.4390.4390

Published: 2015

Journal Articles

Prognostic Impact of Transfusions Intensity on Survival and Development of Thrombocytopenia in Newly Diagnosed Lower-Risk MDS Patients Participating in the European Leukemianet EU-MDS Registry

Blood (2015) 126 (23): 1677.

https://doi.org/10.1182/blood.V126.23.1677.1677

Published: 2015

Journal Articles

Hepcidin and GDF15 Levels during the First 2 Years Follow-up in Patients with Low and Int-1 Risk Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS Registry

Louise De Swart, MD, Chloé Reiniers, Tim Bagguley, Corine van Marrewijk, PhD, David Bowen, MD PhD, Jaroslav Cermak, MD PhD As. Prof., Eva Hellström-Lindberg, MD PhD, Aurelia Tatic, MD, Argiris Symeonidis, MD PhD, Gerwin A Huls, MD PhD, Alex Smith, Theo de Witte, MD PhD

Blood (2014) 124 (21): 3267.

https://doi.org/10.1182/blood.V124.21.3267.3267

Published: 2014

Journal Articles

Anti-CTLA-4 Antibody Is Not Able to Trigger Apoptosis in CTLA-4 Expressing Myeloid Tumor Cells

Sandra van Bijnen, MD, Maria Rogkoti, Marian Withaar, Theo de Witte, MD, PhD, Petra Muus, MD, PhD, Harry Dolstra, PhD

Blood (2011) 118 (21): 5054.

https://doi.org/10.1182/blood.V118.21.5054.5054

Published: 2011

Journal Articles

Transfusion-Dependency Is the Most Important Prognostic Factor for Survival in 1000 Newly Diagnosed MDS Patients with Low- and Intermediate-1 Risk MDS in the European LeukemiaNet MDS Registry

Louise de Swart, Alex Smith, Pierre Fenaux, MD, PhD, David Bowen, Guillermo Sanz, MD, Eva Hellström-Lindberg, Argyris Symeonidis, Jaroslav Cermak, MD, PhD, Ulrich Germing, MD, Reinhard Stauder, MD, Otilia Georgescu, Marius MacKenzie, Luca Malcovati, MD, Mette Skov Holm, MD, PhD, Sophie Park, Odile Beyne-Rauzy, Jackie Droste, Theo de Witte, MD, PhD

Blood (2011) 118 (21): 2775.

https://doi.org/10.1182/blood.V118.21.2775.2775

Published: 2011

Journal Articles

Prognostic Pre-Transplant Factors in Myelodysplastic Syndromes Primarily Treated by Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study on Behalf of the MDS Subcommittee of the Chronic Leukaemia Working Party of the EBMT

Eline Cremers, Anja van Biezen, StatAnalyst, Liesbeth C. de Wreede, PhD, Marijke Scholten, Antonin Vitek, Jürgen Finke, Uwe Platzbecker, MD, Dietrich Beelen, Rainer Schwerdtfeger, Liisa Volin, Nikolaos Harhalakis, Anton Schattenberg, Arnon Nagler, Theo de Witte, MD, PhD, Nicolaus Kröger

Blood (2011) 118 (21): 3014.

https://doi.org/10.1182/blood.V118.21.3014.3014

Published: 2011

Journal Articles

Association of Disparities in Known Minor Histocompatibility Antigens with Relapse-Free Survival and Graft-Versus-Host-Disease Upon Allogeneic Stem Cell Transplantation,

Willemijn Hobo, Kelly Broen, Walter J.F.M. van der Velden, MD, PhD, Annelies Greupink-Draaisma, Niken Adisty, Yannick Wouters, Michel G.D. Kester, Hanny Fredrix, Joop H. Jansen, PhD, Bert A. van der Reijden, PhD, J.H. Frederik Falkenburg, Theo de Witte, MD, PhD, Frank W.M.B. Preijers, PhD, Anton Schattenberg, MD, PhD, Ton Feuth, Nicole N.A. Blijlevens, MD, PhD, Nicolaas Schaap, MD, PhD, Harry Dolstra, PhD

Blood (2011) 118 (21): 4136.

https://doi.org/10.1182/blood.V118.21.4136.4136

Published: 2011

Journal Articles

T Cells Expressing the Activating NK Cell Receptors KIR2DS4, NKG2C and NKG2D Are Elevated In Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Cytotoxic towards Hematopoietic Progenitor Cell Lines

Sandra van Bijnen, MD, Marian Withaar, Frank Preijers, PhD, Arnold van der Meer, PhD, Theo de Witte, MD, PhD, Petra Muus, MD, PhD, Harry Dolstra, PhD

Blood (2010) 116 (21): 2235.

https://doi.org/10.1182/blood.V116.21.2235.2235

Published: 2010

Journal Articles

Chemokine Induction by All-Trans Retinoic Acid in Acute Promyelocytic Leukemia - Triggering the Retinoic Acid Syndrome

Maaike Luesink, MD, Jeroen Pennings, PhD, Willemijn Wissink, Msc, Peter Linssen, Petra Muus, MD, PhD, Rolf Pfundt, PhD, Richard Huijbens, Theo de Witte, MD, PhD, Bert van der Reijden, PhD, Joop H. Jansen, PhD

Blood (2008) 112 (11): 2980.

https://doi.org/10.1182/blood.V112.11.2980.2980

Published: 2008

Journal Articles

Identification of Novel Genetic Lesions in Myelodysplastic Syndromes Using High Density SNP-Arrays.

Saskia Langemeijer, MD, Roland Kuiper, PhD, Peter Vandenberghe, PhD, Estelle Verburgh, MD, Jan Boezeman, PhD, Ad Geurts van Kessel, PhD, Bert van der Reijden, PhD, Theo de Witte, MD, PhD, Joop Jansen, PhD

Blood (2007) 110 (11): 2430.

https://doi.org/10.1182/blood.V110.11.2430.2430

Published: 2007

Journal Articles

A Novel Tissue-Restricted Minor Histocompatibility Antigen Resulting from Differential Expression Due to a Deletion/Insertion Polymorphism in the P2X5 Purinergic Receptor Gene.

Harry Dolstra, PhD, Bjorn de Rijke, Agnes van Horssen, Frans Maas, Britt Otterud, PhD, Elly van de Wiel-van Kemenade, PhD, Theo De Witte, MD, PhD

Blood (2004) 104 (11): 3062.

https://doi.org/10.1182/blood.V104.11.3062.3062

Published: 2004

NARROW

MDS Diagnosis: Many Patients May Not Require Bone Marrow Examination

Deriving Core Patient-Reported Outcomes in Patients with Myelodysplastic Syndromes — a Delphi Survey from the European-MDS Registry

Impact of Treatment with Iron Chelators in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry

An EBMT Prospective Non-Interventional Study of Outcomes and Toxicity of Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Patients Previously Treated with Second Generation Tyrosine Kinase Inhibitors

Elevated Labile Plasma Iron Levels (LPI) and Increased Oxidative Stress Are Associated with Red Blood Cell Transfusions in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Subtitle: from the European Leukemianet MDS Registry

Labile Plasma Iron (LPI) Is a Clinical Indicator of Overt Iron Overload in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS Registry

Allogeneic Stem Cell Transplantation for MDS Patients More Than 70 Years of Age: a Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT

Prognostic Impact of Transfusions Intensity on Survival and Development of Thrombocytopenia in Newly Diagnosed Lower-Risk MDS Patients Participating in the European Leukemianet EU-MDS Registry

Hepcidin and GDF15 Levels during the First 2 Years Follow-up in Patients with Low and Int-1 Risk Myelodysplastic Syndromes (MDS) from the European Leukemianet MDS Registry

Anti-CTLA-4 Antibody Is Not Able to Trigger Apoptosis in CTLA-4 Expressing Myeloid Tumor Cells

Transfusion-Dependency Is the Most Important Prognostic Factor for Survival in 1000 Newly Diagnosed MDS Patients with Low- and Intermediate-1 Risk MDS in the European LeukemiaNet MDS Registry

Prognostic Pre-Transplant Factors in Myelodysplastic Syndromes Primarily Treated by Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study on Behalf of the MDS Subcommittee of the Chronic Leukaemia Working Party of the EBMT

Association of Disparities in Known Minor Histocompatibility Antigens with Relapse-Free Survival and Graft-Versus-Host-Disease Upon Allogeneic Stem Cell Transplantation,

T Cells Expressing the Activating NK Cell Receptors KIR2DS4, NKG2C and NKG2D Are Elevated In Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Cytotoxic towards Hematopoietic Progenitor Cell Lines

Chemokine Induction by All-Trans Retinoic Acid in Acute Promyelocytic Leukemia - Triggering the Retinoic Acid Syndrome

Identification of Novel Genetic Lesions in Myelodysplastic Syndromes Using High Density SNP-Arrays.

A Novel Tissue-Restricted Minor Histocompatibility Antigen Resulting from Differential Expression Due to a Deletion/Insertion Polymorphism in the P2X5 Purinergic Receptor Gene.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only